Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_assertion type Assertion NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_head.
- NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_assertion wasGeneratedBy ECO_0000203 NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_provenance.
- NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_assertion wasDerivedFrom befree-20140225 NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_provenance.
- NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_assertion SIO_000772 16585607 NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_provenance.
- NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_assertion evidence source_evidence_literature NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_provenance.
- NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_assertion description "[Our data indicate that CD4+ immune responses against CEA develop in neoplastic patients, suggesting that tolerance toward CEA or cross-reactive CD66 homologous molecules might be either not absolute or be overcome in the neoplastic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891477.RARgDVd3jwf72Df43fCS7XBbqU1vJGPImO1FpezwPFnK0130_provenance.